Biomarkers in Urothelial Carcinoma

Biomarkers in Urothelial Carcinoma

UChicago Medicine

8 months
40 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Peter O'Donnell, MD of @UChicagoMed explains biomarkers in patients with locally advanced metastatic urothelial carcinoma treated with durvalumab in phase 1/2 dose‐escalation.
Up Next Autoplay